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To test for autoantibodies in patients with vitiligo, skin biop-
sies from 16 patients with active vitiligo and 12 patients with 
stable vitiligo were examined by direct immunofluorescence. 
In periodate-lysine-paraformaldehyde - fixed biopsy speci-
mens, the presence of IgG d.eposits in kera~inocy.tes al~~ ~he 
number of keratinocytes with focal IgG In actlve vitiligo 
were significantly greater than in stable vitiligo. To test 
whether the antibodies to normal human keratinocytes or 
melanocytes are present in vitiligo, we used an indirect im-
munofluorescence test and enzyme-linked immunosorbent 
assay to test the serum of 43 patients. With unfixed viable 
melanocytes, we found a granular pattern ofIgG staining on 
the plasma membrane of melanocytes incubated with pa-
tients' sera but not in cells incubated with the control sera. 
I t has been proposed that the primary disturbance of segmen-tal-type vitiligo lies in the sympathetic nerves of the affected area and that the primary disturbance of non-segmental-type vitiligo lies in the melanocyte itself [1]. It has been reported that immunologic mechanisms may play an impor-
tant role in the pathogenesis of non-segmental-type vitiligo [2,3]. 
Using cultured human melanocytes, Bystryn and co-workers [4,5] 
demonstrated, by immunofluorescence and immunoprecipitation, 
the occurrence of antimelanocyte antibodies in patients with viti-
ligo. Furthermore, these autoantibodies were cytotoxic for target 
cells in patients with vitiligo vulgaris [6,7]. Norris e/ at reported 
that sera of patients with vitiligo damaged human melanocytes ill 
vitro by a complement-mediated mechanism and by antibody-
dependent cellular cytotoxiciry [8]. These reports strongly suggest 
that these cytotoxic autoantibodies may be involved in the patho-
genesis of vitiligo. Foci of vacuolar ~e.g.eneration of basal and para-
basal keratinocytes, also found 111 vltlhgo skm [9 -11] were most 
marked in the normal-appearing skin of patients with rapidly pro-
gressing depigmentation and were often found immediately adja-
cent to melanocytes. Nevertheless, the pathogenesis of the abnor-
mality of keratinocytes in vitili~o is. not clear.. In this st~dy, 
immunofluorescence was used to Identify antibodies to kerat1l10-
cytes in non-segmental vitiligo. An.tikerat~nocyte antib?dies were 
especially prominent in patients with rapidly progress1l1g deplg-
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With methanol-fixed melanocytes, however, we found a ho-
mogeneous pattern ofIgG staining in the cytoplasm of mela-
nocytes. With unfixed viable keratinocytes as targets, there 
was no deposit ofIgG on the cells. A homogeneous pattern of 
IgG binding in the cytoplasm of methanol-fixed keratino-
cytes suggested the presence of antikeratinocyte autoantibo-
dies to cytoplasmic keratinocyte components. The fluores-
cence staining for IgG binding was more prominent in active 
or extensive vitiligo. Vitiligo sera were cytotoxic for melano-
cytes but not for keratinocytes in vitro. Antimelanocytic anti-
bodies may playa role in melanocytotoxicity, whereas anti-
keratinocyte antibodies may occur secondary to cellular 
damage.] Invest DermatoI100:823-828, 1993 
mentation and correlated with the extent of depigmentation in viti-
ligo. 
MATERIALS AND METHODS 
Selection of Patients Only patients with non-segmental idio-
pathic vitiligo were enrolled in this study. The patients had not 
received any treatment for at least 3 months and were grouped 
according to the activity of their disease [9): 1) active vitiligo (newly 
depigmented lesions during the last 3 months); and 2) stable vitiligo 
(no recent depigmented or repigmenting lesions in the 3 months 
prior to examination). Biopsy specimens were collected from 16 
patients with active vitiligo and 12 with stable vitiligo. Three punch 
biopsies (2 or 3 mm in diameter) were taken from each patient 
from three different locations: 1) the center of a depigmented le-
sion; 2) the normally pigmented edge of a lesion; and 3) 2 em from 
the edge of a lesion. The number of specimens obtained and lo-
cations biopsied were 12 from dorsum of hands, five from the 
neck, five from the upper chest, and six from the lower back. 
From eight control subjects, five specimens were obtained from 
clinically normal forearms and three from the dorsa of hands. 
Sera collected from 43 patients (including 23 with active vitiligo 
and 20 with stable vitiligo) and 10 healthy individuals were 
used for the immunologic studies. Both patients and control sub-
jects were age and gender matched. Surface area involvement 111 
patients with vitiligo was estimated according to the "rule of 
nines." 
Preparation of Frozen Tissue Biopsy specimens were cut into 
two parts. One-half of the specimens were placed in periodate-Iy-
sine-paraformaldehyde (PLP) fixative for 75 min at 4°C, washed in 
0.01 M phosphate-buffered saline (PBS) solution (pH 7.4) over-
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Figure 1. Direct immunofluorescence antibod~ stai~ ?fbiopsied specimens after PLP fixation: A) In control sub~ects, neither Ig ~or complement could be 
found deposited in the skin. B) In patients WIth vltlhgo, only IgG was found to be deposIted m focal keratmocytes. The dlstnbutlon of IgG-bound 
keratinocytes ranged from basal layer to granular layer. Bar, 0.04 mm. 
night at 4 ° C, embedded in ornithine carbonyl transferase (Mile 
Lab., Inc.) , and quickly frozen and stored in liquid nitrogen until 
further use [11]. The other half of the specimens were immediately 
frozen and stored in liquid nitrogen without fixation . 
Direct Im munofluorescence Eight-micrometer-thick cryo-
stat sections of specimens (fixed in PLP or unfixed) were incubated 
in fluorescein thiocyanate-conjugated rabbit anti-human immuno-
globulin (I g) G , IgA, IgM, C3, and C1q (1: 20 diluted with 0.01 M 
PBS) at room temperature for 30 min. After being washed thor-
oughly with PBS, the specimens were examined with a Nikon 
UFX-II fluorescence microscope. The number of fluorescent cells 
with bound Ig or complement in each biopsy specimen was ob-
served in three sections and counted per millimeter length of sec-
tions at a magnification of X 100 using a calibrated ocular grid (Net 
Micromete~, Nikon, Japan). 
Culture of Keratinocytes and Melanocytes Adult normal 
human foreskins were used. Keratinocytes and melanocytes were 
established and maintained in culture as previously described 
[13,14] . Second-passage cells were used for indirect immunofluores-
cence, enzyme-linked immunosorbentassay (ELISA), and cytotoxic-
ity assay. The cells were grown in a Lab Tek chamber. 
Indirect Immunofluorescence Forty-three sera of patients and 
10 normal control sera were tested for the presence of antibodies 
against keratinocytes and melanocytes by indirect immunofluores-
cence. The cells, fixed in 100% methanol at -20°C for 2 min or 
unfixed, were incubated with serum (1: 5 diluted in PBS) at 37"C 
for 30 min, washed, and incubated with fluescein isothiocyanate-
conjugated rabbit anti-human IgG, IgM, or IgA (Dako-immuno-
globulins a/ s, Denmar~) at roo~ temperature. for 30 min: Nuclei 
were counterstained With propldlUm IOdide (Sigma Chemical Co.) 
Table I. Comparison of Number of Keratinocytes 
with Bound IgG in PLP-Fixed Specimens Taken 
from Depigmented Lesions, Edge of Lesions, and 2 em Away 
from Edge of Lesions by Direct Immunofluorescence" 
Disease Activity 
Active Vitiligo Stable Vitiligo 
Site of Biopsy (n = 16) (n = ' 12) p Value 
Clinically normal skin 
2 em from edge of 
9.6 ± 0.7' 1.4 ± 0.3 < 0.05 
lesion 
at edge of lesion 12.4 ± 1.2 1.9 ± 0.4 < 0.05 
Center of depigmented 15.9 ± 1.4 2.1 ± 0.5 < 0.05 
lesion 
• Values arc means ± SD/mm length of frozen sections. 
(50 /1g/ml in PBS) in the dark at room temperature for 30 min and 
mounted in 90% glycerol. Between each step, the specimens were 
washed with 0.01 M PBS (pH 7.2). 
ELISA of Cells Assay procedures were modified from the meth-
ods of Hashemi et af [15] . The melanocytes or keratinocytes were 
subcultured into six-well flat-bottomed tissue culture plates (Falcon 
3072, Becton Dickinson) at a concentration of 2 X 104 • cells/well 
and used after 24-h. In brief, cells were fixed in 100% ice-cold 
methanol for 3 min, washed three times with PBS, and incubated 
with 150/11 diluted sera (1 : 5 diluted in PBS) at room temperature 
for 30 min. Sera included 43 patients with vitiligo and 10 normal 
control subjects . After washing with PBS three times, we added 
100/11 of rabbit anti-human IgG (1: 50 diluted) (Cappel, Organon 
Teknika) for 30 min at room temperature. Unbound rabbit anti-
serum was removed by washing the well three times with PBS, and 
a pig anti-rabbit peroxidase anti-peroxidase kit (Dako PAP Kit, 
K548) was used according to the manufacturer's instructions. plates 
were read at 405 nm in an ELISA reader (ultraviolet maximum, 
kinetic microplate reader, Molecular Devices), and the relative titer 
of antimelanocyte or antikeratinocyte antibodies was expressed as 
optical density. 
Lactoperoxidase-Catalyzed Radioiodination and Immuno-
precipitation Assay Ten sera containing antikeratinocyte anti-
bodies according to indirect immunofluorescence were reacted with 
lysates of radioiodinated keratinocytes to detect surface macromole-
cules. The cultured keratinocytes were radioiodinated by the lacto-
peroxidase method, as reported by Naughton et af [4,5). 12sI-sodium 
radioiodinated cell lysate was precipitated with 10% trichloroacetic 
acid, and the associated radioactivity was measured. A specific im-
munoprecipitation method with protein A Sepharose was used to 
detect antibodies in sera [4,5) . Specific binding was calculated by 
subtracting the counts per minute bound by an equal volume of 
control serum from the average counts per minute bound by test 
serum. The same control serum was used in all studies. Sera 
were considered positive for antibodies when 2.5% or more of the 
trichloroacetic acid-insoluble radioactivity was bound specifi-
cally. 
Cytotoxicity Assay The cytotoxicity of various sera for keratino-
cytes and melanocytes was measured using fluorescein diacetate 
(Nutritional Biochemical)/ethidium bromide (Sigma) [16]. The 
source of antibodies for this study was sera from 10 patients with 
vitiligo and 10 control subjects that were heat inactivated for 1 hat 
56 ° C to inactivate complement. Fresh rabbit serum (Cedarlane Lab-
oratories) as complement source and normal mononuclear cells sepa-
rated by Ficoll-Hypaque (Phamacia, LKB, Sweden) as effector cells 
were added to each chamber of the Lab Tek chambers. Different 
combinations of test sera (50/11), complement source (50 /11), or 
effectors (5 X 104/chamber to make an effector/target ratio of 
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figure 2. Indirect immunofluorescence of viable and methanol-fixed cultured melanocytes or keratinocytes with different sera. A) Evidence to show the 
presence of antibodies to unfixed cultured melanocytes in serum of patients with active vitiligo, which was detected as granular pattern of fluorescence (arrow) 
on the cell surface. Bar, 0.01 mm. B) No granular pattern of fluorescence was found 111 unfixed melanocytes after incubation in serum of patients with stable 
vitiligo . Bar, 0.01 mm. C) In methanol-fixed melanocytes, homogeneous fluorescence was found in the cytoplasm. Bar, 0.04 mm. D) In methanol-fixed 
keratinocytes, the fluorescence also appeared in a cytoplasmic pattern. Bar, 0.04 mm. 
1: 10) w-ere added to each chamber in a total volume of 1 ml and 
were incubated at 37°C for 16 h in a humidified atmosphere of8% 
CO 2 and 92% air. After 16 h, 1 ml of fluorescein diacetate/ethi-
dium bromide solution (containing 10 Jlg/ml fluorescein diacetate 
and 1 ppm ethidium bromide) was added at room temperature for 4 
min. A total number of 200 cells was observed using an Olympus 
IMT -2 inverted fluorescence microscope. Nonfluorescent fluores-
cein diacetate is hydrolyzed inside the cells by esterase. permitting 
fl uorescence of fluorescein, which accumulates in undamaged cells 
Table II. Comparison of Incidence of Antimelanocyte (Anti-
Me) and Antikeratinocyte (Anti-KC) Autoantibodies (Ab) in 
Patients with Active and Stable Vitiligo and Normal Control 
Subjects in Viable or Methanol-Fixed Cellso 
Anti-MC Ab 
Anti-KC Ab, 
Disease Number of Granular Homogeneous Homogeneous 
Activity Patients Patternb Pattern' Pattern' 
Active 23 65% 87% 39% 
Stable 20 50% 70% 10% 
Total 43 58% 79% 26% 
• Data are percent of number of patients' sera showing positive fluorescence reaction 
in total sera examined. 
I Granular pattern of fluorescence was visible on th~ cell surface of viable cells. 
, HOIDogcneous distribution of fluorescence was vlSlble m the cytoplasm of cells of 
fixed cells. 
but leaks out of damaged cells. In damaged cells. the ethidium 
bromide enters the nucleus and is intercalated with ONA to emit 
orange-red fluorescence. As a result. the cytoplasm of cells with 
intact membranes stained green. whereas nuclei of damaged cells 
were orange. The results of the cytotoxicity assay are shown as the 
percent of cells with orange-red fluorescence in a total of200 cells. 
Statistical Analysis Experiments in triplicate from each serum 
of patients or normal control subjects were analyzed by ELISA 
and cytotoxicity assay. Results are presented as the mean ± SO. 
Statistical analysis of results was performed by using the Student t 
test. 
RESULTS 
Direct Immunofluorescence In biopsy specimens without PLP 
fixation. no deposit of IgG, IgM. IgA. or complement (C? C1q) 
was observed either in patients with vitiligo or in control subJect~ . In 
biopsy specimens of normal control subjects with PLP fixatlO~. 
neither Ig nor complement could be found . On the other hand. 111 
fixed biopsy specimens of patients with vitiligo. there was no IgA, 
IgM. or complement (Clq. C3). but IgG was found in focal kerati-
nocytes (Fig 1). The results are summarized in Table I. The nUl:nb~r 
of keratinocytes with bound IgG per millimeter length of sk1l1 111 
active vitiligo was significantly higher than in stable vitiligo. In 
active vitiligo. the cells with bound IgG decreased in number from 
the depigmented area to the normally pigmented skin. whereas 
there was a negligible change in stable vitiligo. The distribution of 
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Figure 3. In antibody-dependent cellular cytotoxiciry assay, there is strong green fluorescence in the cytoplasm of undamaged cells, but the fluorescence leaks 
from the damaged cells, revealing "shadow" fluorescence. A) Most cells show strong fluorescence after incubation with control serum. B) After incubation 
with patients' sera, ma.ny cells show "shadow" fluorescence (arrow). Bar, 0.04 mm. 
IgG-bound keratinocytes ranged from the basal to the granular cell 
layer. 
Indirect Immunofluorescence Indirect immunofluorescence, 
using unfixed viable keratinocytes, revealed no bound IgG, but in 
unfixed melanocytes a granular pattern of fluorescence on the sur-
face of the cells was observed (Fig 2) . In methanol-fixed cultured 
cells, most of the cells attached to the well wall after the staining 
process. IgG antibodies were detected in the cytoplasm of both 
keratinocytes and melanocytes in a homogeneous pattern (Fig 2). 
There was a higher incidence of antimelanocyte antibodies (79%) 
than of antikeratinocyte antibodies (26%) (Table II), and both auto-
antibodies were present more often in active vitiligo than in stable 
vitiligo. None of the control sera produced fluorescence. 
ELISA Utilizing the methanol-fixed cells in an ELISA test, we 
compared the titer of antimelanocyte and antikeratinocyte antibod-
ies in sera (Fig 3). The mean optical density produced by both 
antibodies was significantly higher in the sera of patients with viti-
ligo than in normal sera. In unfixed cells, no conclusive results could 
be obtained because the cells detached from the wells during stain-
ing. 
Correlation Between Autoantibodies and Extent of De-
pigmentation Using indirect immunofluorescence to stain fixed 
cells, we found a correlation between the incidence of antimelano-
cyte and antikeratinocyte antibodies and the extent of depigmented 
skin in patients with vitiligo (Table III) (i.e., the more the surface 
Table III. Correlation of Incidence of Antimelanocyte 
(Anti-Me) and Antikeratinocyte (Anti-Ke) Autoantibodies 
(A b) in Serum and Extent of Depigmented 
Lesions in Patients with Viti ligo 
Surface 
Area of Anti-MCAb 
Involvement 
(% of whole Number of Granular Homogeneous 
body) Patients Patternb Pattern' 
< 10 24 14 (59)' 18 (75) 
10-40 14 9 (64) 11 (79) 
40 - 80 3 3 (100) 3 (100) 
>80 2 2 (100) 2 (100) 
Total 43 28 (65) 34 (79) 
• Values are number of patients (percent of total patients). 
b Viable cells . 









area of involvement, the higher the incidence of anti melanocyte 
and antikeratinocyte antibodies in the serum sample) . 
Immunoprecipitation Assay Ten sera from patients with viti-
ligo were tested by specific immunoprecipitation of antikeratino-
cyte antibodies. No sera showed specific binding greater than 2.5% 
(data not shown). It is possible that the epitopes for antikeratinocyte 
antibodies are present in the cytoplasm rather than on the surface of 
the cells and could not be detected by the method used. 
Cytotoxicity Assay The sera of patients with vitiligo did not 
cause any apparent cytotoxic effect on cultured keratinocytes, either 
by complement-dependent or by antibody-dependent cell-mediated 
cytotoxicity. Patients' sera, however, induced marked cytotoxicity 
on melanocytes (Fig 4) by both immune mechanisms. Antibody-de-
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Figure 4. Comparison of the titer of antimelanocyte and antikeratinocyte 
antibodies in sera of patients with vitiligo or normal control subjects by 
ELISA using methanol-fixed keratinocytes or melanocytes. The mean opti-
cal densiry of both antibodies was significantly higher in the sera of patients 
with vitiligo than in normal sera. 
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Table IV. Cytotoxic Effect of Vitiligo Sera on Keratinocytes 
and Melanocytes by Use of Complement-Media.ted (Method A) 





(n = 10) 
9.7 ± 1.9 
13.7 ± 2.6 
Control 
Subjects 
(n = 10) 
3.5 ± 0.8 
8.7 ± 1.6 




(n = 10) 
55.4 ± 5.1 
67.2 ± 4.9 
Control 
Subjects 
(n = 10) 
10.7 ± 6.9 
12.5 ± 2.5 
. rendent cellular toxicity for melanocytes was found more often 
;,han complement-mediated damage (Table IV) . 
DISCUSSION 
,Antixnelanocyte Antibodi~s .. The ass~ciation of mel~nocyte 
cell-surface antibodies with vmhgo vul~~ls ~as first descn?ed ?y 
Naughton et at who used immunopreclpltatlOn [4,5]. Antibodies 
could also be demonstrated by indirect imm~n~fluores~ence and 
exhibited typical granular patter~s o~ surface stammg on viable mel-
,nocytes similar to that shown In Fig 2. We found, however, that 
cultured melanocytes fixed in methanol for 2 min, which permeabi-
Jizes the cell membrane, showed h~mogeneous patterns of fluares-
~nce in the cytoplasm. The .two different p~tterns. of fluorescence 
Jistribution have generated Interest among ~nvest.lgat,?rs, and the 
pature and autoantigens ?f ~hese cytopla.sml~ antibodies are now 
pnder investigation. The Incidence o~ anub?dles ~o surfa.ce and cy-
,oplasmic antigens is sig~ifican~ly h~~I~er In active pauel~ts ~Ith 
~itiligo than in stable patients with vitilIgo, as revealed by indirect 
jmmunofluorescence (Table II) and ELISA (Fig 3). The data also 
jhow that the greater the involved s~in surface area,. the higher the 
'ncidence of antibodies to cytoplasmiC or surface antigens, as shown ~y indirect immunofluorescence (Table IV) and in agreement with 
I previous report b~ Na~ght,?n et at [17]. It has been reported that 
/Otim.elanocyte antlbo~les hll melanocytes by comple~~nt-me­
Jiated lysis and by antibody-dependent cellular ~ytOtOXIClty [13] 
Ind that cytotoxicity for melan~cytes o~ the latter IS more effective 
,han complement-mediate? lys~s: ~n thiS ~t~dy, we. confirmed t1~at 
,he sera of patients with active VitilIgo exhibit prominent cytotoxlc-
'ry for melanocytes (Table IV) . Because the Fc receptor is not ~resent on the surface of melanocytes [18], anticytoplasmic antibod-
Ies are unable to penetrate the cyto'p~asm via the Fc recept?r. TI~ere­
fore, it is proposed that ~yto~oxlc.lty for me~anocytes 111 vI~lhgo 
Jepends primarily on antlbo~les d~rected against surface an~lgens 
rather than against cytoplasmiC antI~en~. The presence of.antIcyto-
lasm.ic antibodies may serve as an I~dlcat~r of t~e sever!ty of ~he 
aisease because they are more prominent In patients with active 
vitiligo ~ith extensive lesions. 
By direct immunofluorescence, we ~ound no IgG bound t.o mela-
pocytes either in fixed or unfixed tissues (Table I) . By mdtrect 
jmmunofluorescence, however, antimelanocyte antibodies that 
(eacted ~ith both viable a~d fi~~~ cultu:ed m:lanocytes were de-
,ected in sera of patie~ts with VItI!lgo. It IS pO.SSlble. that the process 
of freezing and thaw111g of specimens for dlrect Immunofluore~­
cence may alter the antigenicity of both surface ~nd ~ytoplasmlc 
,ntibodies or cause the shedding of these bound antibodies fro~ the 
cell. Alternatively, cultured mel~nocy!es may expre~s mar.e antigen 
fhan skin specimens and may be Identified more eaSily by Immuno-
fluorescence. . . 
It is not clear why by indirect immunofluo.rescence a sl~mficantly 
different fluorescence pattern is observed 111 unfixed viable cells 
(granular pattern) than in methanol-fi~ed cells (homogeneous pat-
tern). One explanation is that fixatI.on In methanol may alter 
the antigenicity of certain surface antigens but preserve the cyto-
plasm.ic antigens. Therefore, 111 methanol-fixed cells, the antlcyto-
plasmic antibodies may penetrate the cytoplasm and react with 
cytoplasmic antigens. Cross-reactivity between these two auto-
antibodies was not found in the present srudy. Absorption of patient 
serum with viable melanocytes followed by reaction with the fixed 
cells or vice versa is now being studied to investigate this problem. 
Antikeratinocyte Antibodies In this study, direct immunofluo-
rescence revealed focal keratinocytes with bound IgG in patients 
with vitiligo. This observation has not been previously reported. 
The distribution of these cells does not coincide with the distribu-
tion of degenerated keratinocytes, but the number of cells with 
bound IgG in active vitiligo is significantly greater than that in 
stable vitiligo. It is possible that the melanocytes that survive an 
immunologic reaction may transfer membrane-bound immuno-
reactants to the surrounding keratinocytes in the same epidermal 
melanin unit [19]. These immunoreactants may be processed by 
neighboring keratinocytes in such a way that these keratinocytes 
become positive by direct immunofluorescence. The binding ofIgG 
on the focal collections of keratinocytes is not cytotoxic. This may 
explain why only focal keratinocytes show IgG deposition and 
staining that does not coincide with degeneration of keratinocytes. 
By indirect immunofluorescence, only a homogeneous yattern of 
fluorescence was found in fixed cultured cells, and no fluorescent 
deposits were found in unfixed cells. This indicates that the sera of 
patients with vitiligo contain anticytoplasmic antibodies rather than 
antibodies against surface antigens. This possibility is consistent 
with negative results in the specific immunoprecipitation assay in 
our study. It is possible that antikeratinocyte antibodies in sera of 
patients with vitiligo result from cell death during the disease pro-
cess and are not pathogenic. 
This study also provides evidence for a correlation between the 
existence of antibodies and the extent of vitiligo. Two other origi-
nal and interesting observations were found in the present study: 1) 
there is a lower incidence and level of antikeratinocyte antibodies 
compared with the antimelanocyte antibodies; and 2) patients' sera 
showed cytotoxicity for melanocytes but not for keratinocytes. Al-
though the origin of antikeratinocyte antibodies in patients' sera is 
not well known, it is reported that in active vitiligo, the keratino-
cytes surrounding melanocytes are d;lmaged and show granular de-
generation [9 -11). The resulting keratinocyte debris or neoanti-
gens released after cell destruction may result in the production 
of antikeratinocyte antibodies [20]. Antikeratinocyte antibodies 
may serve as a marker for the assessment of disease activity of viti-
ligo. 
This study was SIIpported by the National Science COlwcil of the Republic of Chilla 
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